NEWS
Desai Grant on Factor XIa Inhibitors Funded

Desai Grant on Factor XIa Inhibitors Funded

Umesh Desai, VaDDC executive committee member and chair of Virginia Commonwealth University's medicinal chemistry department, has just received an R61/33 grant to develop allosteric inhibitors of coagulation factor XIa.  The grant, titled "Lead Identification and...

KeViRx-UVA-ODU Collaborative SBIR Grant funded

KeViRx-UVA-ODU Collaborative SBIR Grant funded

KeViRx is an early stage drug discovery company spun out of the UVA Department of Pharmacology by Elizabeth Sharlow and John Lazo and is located in Charlottesville. KeViRx was just awarded its second National Institutes of Health R43 Phase 1 Small Business Innovation...

Virginia Bio Names John Newby CEO

Virginia Bio Names John Newby CEO

Virginia Bio announces John Newby will become CEO of Virginia Bio starting August 5, 2019. John will be stepping down as Commissioner of the Virginia Department of Veterans Services, where for the last 7 years he led this 800-member Agency located across more than 40...